CFTR and chronic obstructive pulmonary disease: Consequently, Trikafta restored the PM expression of R75Q- or M470V-CFTR even in the presence of environmental pathogens and pollutants, thereby suppressing the excess inflammatory response, which may lead to COPD pathogenesis (Figure 9).